Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

RCT (n=277) reports mean number of ventilator-free days at 28 days post randomisation was higher in the dexamethasone group than in the control group (between-group difference 4.8 days [95% CI 2.57 to 7.03]; p<0.0001).

Source:

The Lancet Respiratory Medicine